Search research articles
Contact Us
Filters
Showing results (181-190 of 539) with videos related to
Page
of 54
Sort By:
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Cancers
|
September 28, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, et al.
Haematologica
|
November 22, 2011
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma
Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
European Journal of Heart Failure
|
March 14, 2007
Non-invasive predictors of survival in cardiac amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
NPJ Digital Medicine
|
April 30, 2025
Predicting progression events in multiple myeloma from routine blood work
Maximilian Ferle, Nora Grieb, Markus Kreuz, et al.
Oncotarget
|
October 17, 2015
miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression
Anja Seckinger, Tobias Meißner, Jérôme Moreaux, et al.
Leukemia & Lymphoma
|
November 6, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison
Maria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt, et al.
British Journal of Haematology
|
August 25, 2021
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantation
Elias K Mai, Thomas Schmitt, Aleksandar Radujkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens
Tilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Page
of 54
Search research articles
Search
Showing results (181-190 of 539) with videos related to
Sort By:
Page
of 54
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Cancers
|
September 28, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, et al.
Haematologica
|
November 22, 2011
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma
Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
European Journal of Heart Failure
|
March 14, 2007
Non-invasive predictors of survival in cardiac amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
NPJ Digital Medicine
|
April 30, 2025
Predicting progression events in multiple myeloma from routine blood work
Maximilian Ferle, Nora Grieb, Markus Kreuz, et al.
Oncotarget
|
October 17, 2015
miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression
Anja Seckinger, Tobias Meißner, Jérôme Moreaux, et al.
Leukemia & Lymphoma
|
November 6, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison
Maria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt, et al.
British Journal of Haematology
|
August 25, 2021
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantation
Elias K Mai, Thomas Schmitt, Aleksandar Radujkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens
Tilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Page
of 54